Pharmascience Inc Company Profile
What is the competitive landscape for PHARMASCIENCE INC
PHARMASCIENCE INC has four approved drugs.
There is one tentative approval on PHARMASCIENCE INC drugs.
Summary for Pharmascience Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
| Patent Litigation for Pharmascience Inc: | See patent lawsuits for Pharmascience Inc |
Drugs and US Patents for Pharmascience Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmascience Inc | DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 204607-001 | May 31, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmascience Inc | GANCICLOVIR SODIUM | ganciclovir sodium | INJECTABLE;INJECTION | 207645-001 | Dec 8, 2017 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmascience Inc | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 208392-001 | May 2, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
